ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment

ClinicalTrials.gov ID: NCT02408445

Public ClinicalTrials.gov record NCT02408445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02408445
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
University of Colorado, Denver
Other
Enrollment
20 participants

Conditions and interventions

Interventions

  • testosterone cypionate 200mg/ml Drug

Drug

Eligibility (public fields only)

Age range
42 Days to 108 Days
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 7, 2015
Primary completion
Jan 30, 2018
Completion
Dec 31, 2019
Last update posted
Apr 14, 2020

2015 – 2020

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Children's Hospital Colorado Aurora Colorado 80045

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02408445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2020 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02408445 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →